
Currently out of the existing stock ratings of Greg Harrison, 109 are a BUY (70.32%), 34 are a HOLD (21.94%), 12 are a SELL (7.74%).
Analyst Greg Harrison, currently employed at BAML, has had 57.95% of price targets met with an average potential upside of 38.84%, reached in 155 days on average.
Greg Harrison has documented 304 price targets and ratings displayed on 28 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 30-Mar-2026.
Analyst best performing recommendations are on OMER (OMEROS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) on 7/30/2025. The price target of $22 was fulfilled within 1 day with a profit of $3 (15.79%), with a performance score of 157.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6.25
$25
4 years 5 months 29 days ago
(23-May-2022)
1/3 (33.33%)
$0.9 (16.82%)
14
Buy
$11
5 years 9 months 4 days ago
(17-Feb-2021)
1/1 (100%)
$-23.25 (-67.88%)
998
Buy
$125
6 years 6 months 13 days ago
(08-May-2020)
0/1 (0%)
$54 (76.06%)
What Year was the first public recommendation made by Greg Harrison?